| Code | Display |
| 31357.100004300 |
Greatest dimension of largest invasive focus greater than 1 mm (specify exact measurement in Millimeters (mm)) |
| 30148.100004300 |
Tumor Size (Note E) |
| 51180.100004300 |
Tumor Site (Note B) |
| 16448.100004300 |
Single focus of invasive carcinoma |
| 38392.100004300 |
Tumor Focality (Note F) |
| 16214.100004300 |
Specimen Laterality |
| 16215.100004300 |
Right |
| 52399.100004300 |
HER2 (by immunohistochemistry) |
| 36944.100004300 |
HER2 (by immunohistochemistry) |
| 43789.100004300 |
Breast Biomarker Testing Performed on Previous Biopsy |
| 41776.100004300 |
Estrogen Receptor (ER) |
| 45138.100004300 |
Estrogen Receptor (ER) Status |
| 53472.100004300 |
Cannot be determined (indeterminate) |
| 16280.100004300 |
Invasive carcinoma of no special type (ductal) |
| 41794.100004300 |
Histologic Type (Note C) |
| 16182.100004300 |
SPECIMEN |
| 17834.100004300 |
SPECIAL STUDIES |
| 39858.100004300 |
Regional Lymph Nodes |
| 16697.100004300 |
REGIONAL LYMPH NODES (Note M) |
| 16717.100004300 |
PATHOLOGIC STAGE CLASSIFICATION (pTNM, AJCC 8th Edition) (Note M) |
| 16567.100004300 |
MARGINS (Note L) |
| 868263.100004300 |
Lymph Nodes |
| 352333.100004300 |
DISTANT METASTASIS |
| 381061.100004300 |
COMMENTS |
| 16782.100004300 |
ADDITIONAL FINDINGS (Note N) |
| 351607.100004300 |
?Number of Sentinel Nodes Examined (if applicable) |
| 351606.100004300 |
Exact number (specify) |
| 351601.100004300 |
Exact number (specify) |
| 351602.100004300 |
Total Number of Lymph Nodes Examined (sentinel and non-sentinel) |
| 374353.100004300 |
Regional lymph nodes present |
| 351589.100004300 |
Regional Lymph Node Status |
| 16736.100004300 |
pT1b: Tumor > 5 mm but <= 10 mm in greatest dimension |
| 327740.100004300 |
pT Category |
| 763178.100004300 |
pN Category |
| 38649.100004300 |
pN0: No regional lymph node metastasis identified or ITCs only# |
| 58807.100004300 |
Procedure (Note A) |
| 40307.100004300 |
Excision (less than total mastectomy) |
| 38391.100004300 |
Overall Grade |
| 16390.100004300 |
Grade 1 (scores of 3, 4 or 5) |
| 380283.100004300 |
Nottingham Score |
| 38125.100004300 |
Nuclear Pleomorphism |
| 16355.100004300 |
Score 2 (Cells larger than normal with open vesicular nuclei, visible nucleoli, and moderate variability in both size and shape) |
| 16383.100004300 |
Score 1 |
| 38390.100004300 |
Mitotic Rate |
| 351503.100004300 |
?Margin Status for Invasive Carcinoma (required only if residual invasive carcinoma is present in specimen) |
| 351504.100004300 |
All margins negative for invasive carcinoma |
| 351501.100004300 |
Lateral |
| 16348.100004300 |
Score 2 (10 to 75% of tumor area forming glandular / tubular structures) |
| 38124.100004300 |
Glandular (Acinar) / Tubular Differentiation |
| 44040.100004300 |
Ductal Carcinoma In Situ (DCIS) (Note G) |
| 16306.100004300 |
Not identified |
| 352343.100004300 |
?Not applicable |
| 42418.100004300 |
Clock position |
| 352334.100004300 |
?Distant Site(s) Involved, if applicable |
| 16259.100004300 |
Specify Clock Position |
| 6643.100004300 |
8 o'clock |
| 16783.100004300 |
Additional Findings (specify) |
| 31359.100004300 |
Additional Dimension in Millimeters (mm) |
| Breast.Invasive.Res.189_4.009.021.REL_sdcFDF |
INVASIVE CARCINOMA OF THE BREAST: Resection |
| 16249.100004300 |
TUMOR |
| 16403.100004300 |
Tumor Extent (Note H) |
| 868258.100004300 |
Primary Tumor Bed |
| 868272.100004300 |
RCB Calculations |
|
Propose a change